• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植后长期孤立性血小板减少症患者骨髓免疫微环境的异常

Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.

作者信息

Song Yang, Shi Min-Min, Zhang Yuan-Yuan, Mo Xiao-Dong, Wang Yu, Zhang Xiao-Hui, Xu Lan-Ping, Huang Xiao-Jun, Kong Yuan

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.

出版信息

Biol Blood Marrow Transplant. 2017 Jun;23(6):906-912. doi: 10.1016/j.bbmt.2017.02.021. Epub 2017 Mar 9.

DOI:10.1016/j.bbmt.2017.02.021
PMID:28286199
Abstract

Prolonged isolated thrombocytopenia (PT) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Whether abnormalities of the bone marrow (BM) immune microenvironment are involved in the pathogenesis of PT remains unknown, however. Twenty patients with PT, 40 matched patients with good graft function (GGF) after allo-HSCT, and 20 healthy donors (HD) were enrolled in this nested case-control study. Th1, Th2, Tc1, Tc2, Th17, and Treg cells were analyzed by flow cytometry, and IFN-γ, IL-4, IL-17, IL-6, IL-21, and thrombopoietin levels in BM plasma were evaluated with a cytometric bead assay and ELISA. Relative to GGF patients and HD controls, PT patients had significantly higher proportions of Th1 and Tc1 cells, resulting in higher Th1/Th2 and Tc1/Tc2 ratios in the BM microenvironment. In addition, the excessive polarization of Th17 was observed in patients with PT. Changes in BM plasma cytokines were consistent with our cellular findings. These results suggest that dysregulated T cell responses in the BM microenvironment might play an important role in the pathogenesis of PT.

摘要

长期孤立性血小板减少症(PT)是异基因造血干细胞移植(allo-HSCT)后的一种严重并发症。然而,骨髓(BM)免疫微环境异常是否参与PT的发病机制尚不清楚。本巢式病例对照研究纳入了20例PT患者、40例allo-HSCT后移植功能良好(GGF)的匹配患者以及20名健康供者(HD)。通过流式细胞术分析Th1、Th2、Tc1、Tc2、Th17和调节性T细胞(Treg),并采用细胞计数微球分析和酶联免疫吸附测定法评估BM血浆中干扰素-γ(IFN-γ)、白细胞介素-4(IL-4)、白细胞介素-17(IL-17)、白细胞介素-6(IL-6)、白细胞介素-21和血小板生成素水平。相对于GGF患者和HD对照组,PT患者的Th1和Tc1细胞比例显著更高,导致BM微环境中Th1/Th2和Tc1/Tc2比值更高。此外,在PT患者中观察到Th17过度极化。BM血浆细胞因子的变化与我们的细胞研究结果一致。这些结果表明,BM微环境中T细胞反应失调可能在PT的发病机制中起重要作用。

相似文献

1
Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后长期孤立性血小板减少症患者骨髓免疫微环境的异常
Biol Blood Marrow Transplant. 2017 Jun;23(6):906-912. doi: 10.1016/j.bbmt.2017.02.021. Epub 2017 Mar 9.
2
Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后移植物功能不良患者骨髓微环境中异常的T细胞反应。
J Transl Med. 2017 Mar 14;15(1):57. doi: 10.1186/s12967-017-1159-y.
3
Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后移植物功能不良患者骨髓免疫微环境中1型免疫反应增强。
Biol Blood Marrow Transplant. 2016 Aug;22(8):1376-1382. doi: 10.1016/j.bbmt.2016.04.016. Epub 2016 Apr 27.
4
Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后骨髓血管微环境受损与持续性孤立性血小板减少症之间的关联。
Biol Blood Marrow Transplant. 2014 Aug;20(8):1190-7. doi: 10.1016/j.bbmt.2014.04.015. Epub 2014 May 2.
5
Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia.免疫性血小板减少症患者骨髓免疫微环境的异常
Ann Hematol. 2016 May;95(6):959-65. doi: 10.1007/s00277-016-2641-y. Epub 2016 Mar 18.
6
Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后骨髓微环境受损与移植物功能继发性不良相关。
Biol Blood Marrow Transplant. 2013 Oct;19(10):1465-73. doi: 10.1016/j.bbmt.2013.07.014. Epub 2013 Jul 20.
7
N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation.N-乙酰半胱氨酸可改善异基因造血干细胞移植后长期孤立性血小板减少症患者的骨髓内皮祖细胞。
Am J Hematol. 2018 Jul;93(7):931-942. doi: 10.1002/ajh.25056. Epub 2018 Feb 24.
8
Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.CD8(+) T细胞募集至骨髓可能解释了在异基因造血干细胞移植后长期孤立性血小板减少症中,通过CX3CR1(+)的高表达对巨核细胞凋亡的抑制作用。
Ann Hematol. 2015 Oct;94(10):1689-98. doi: 10.1007/s00277-015-2436-6. Epub 2015 Jul 5.
9
Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.再生障碍性贫血患者接受异基因造血干细胞移植后,血管和血管周围龛位数量得以恢复,但成骨细胞龛位未恢复。
Int J Hematol. 2017 Jul;106(1):71-81. doi: 10.1007/s12185-017-2217-1. Epub 2017 Mar 16.
10
The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.核因子红细胞2相关因子2激动剂叔丁基对苯二酚可改善异基因造血干细胞移植后长期孤立性血小板减少症中骨髓间充质基质细胞的功能。
Br J Haematol. 2023 Mar;200(6):759-768. doi: 10.1111/bjh.18585. Epub 2022 Dec 4.

引用本文的文献

1
Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway.预防性高压氧治疗通过激活Nrf2/HO-1通路改善急性移植物抗宿主病。
Front Immunol. 2025 Feb 27;16:1529176. doi: 10.3389/fimmu.2025.1529176. eCollection 2025.
2
Model-Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.基于模型的异基因造血干细胞移植后临床相关血小板减少症的预测
Clin Pharmacol Ther. 2025 May;117(5):1413-1426. doi: 10.1002/cpt.3580. Epub 2025 Feb 6.
3
Efficacy and safety of hetrombopag in the treatment of recombinant human thrombopoietin-resistant thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
艾曲泊帕治疗异基因造血干细胞移植后重组人血小板生成素抵抗性血小板减少症的疗效和安全性。
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102578. doi: 10.1016/j.rpth.2024.102578. eCollection 2024 Oct.
4
Checkpoint Inhibitors in Acute Myeloid Leukemia.急性髓系白血病中的检查点抑制剂
Biomedicines. 2023 Jun 15;11(6):1724. doi: 10.3390/biomedicines11061724.
5
Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia.功能失调的骨髓内皮细胞的修复可缓解再生障碍性贫血。
Sci China Life Sci. 2023 Nov;66(11):2553-2570. doi: 10.1007/s11427-022-2310-x. Epub 2023 Jun 5.
6
Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation.造血干细胞移植后骨髓增生异常综合征中血小板减少症的预后价值
Front Oncol. 2022 Jul 11;12:940320. doi: 10.3389/fonc.2022.940320. eCollection 2022.
7
Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation.分析阿伐曲泊帕联合间充质干细胞治疗异基因造血干细胞移植后血小板减少症的疗效和安全性。
Front Immunol. 2022 May 27;13:910893. doi: 10.3389/fimmu.2022.910893. eCollection 2022.
8
Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.骨髓内皮祖细胞功能障碍与骨髓增生异常综合征患者有关。
J Transl Med. 2022 Mar 29;20(1):144. doi: 10.1186/s12967-022-03354-2.
9
Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后的血小板减少症及治疗策略
J Clin Med. 2022 Mar 2;11(5):1364. doi: 10.3390/jcm11051364.
10
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.依鲁替尼治疗单倍体外周血造血干细胞移植后持续性血小板减少症患者的疗效:单中心经验。
Ann Hematol. 2022 Feb;101(2):397-408. doi: 10.1007/s00277-021-04706-6. Epub 2021 Nov 4.